Tuesday, February 12, 2013

Proctor & Gamble (Electronic Data Capture)



Sir,
Ray D’ Alonzo earlier provided background on a new directive to streamline our prescription drug implementation strategy. It was a detailed presentation from the beginning stages involving R&D and clinical trials all the way to our prescription drugs reaching the consumer and hitting the market. To provide some clarification, I will describe and reiterate his main selling points. Mr. D’ Alonzo understands the role technology plays in business and plans on creating a more efficient process to save money and time.

Our prescription drug business accounts for 11% of our total sales. Although, not an astonishing figure, this sector of the business is highly profitable. There are many factors to consider when discussing the life cycle of a specific drug. Obviously the R&D plays a major role but the aspect of the process that needs improving is that of the clinical trials and the way patient data is recorded.  The current paper-process is cumbersome and difficult to track. As you know CRA’s meet with investigator sites to work together to ensure accurate data is inputted. This interaction is another major cog in the wheel that needs improving. Significant time is wasted when the paper is shipped and pertinent data is in “lock” phase. Information is not exchanged instantaneously which creates backlog and overall poor project tracking. Improvements can be sustained in nearly every aspect of the described procedure, several of which will be outlined shortly.

To increase efficiency and significantly shorten these process three options were considered; improve existing paper-based process, digital imaging and web enabled/EDC (Electronic Data Capture). The first option being to improve already existing paper based process would require express mail shipments and increased staffing. Although, these efforts would reduce overall time, it is rather expensive and regardless paper in a digital world is slow. The second option, digital imaging, is nearly impossible when considering the cost required to store data. There is a slight increase in efficiency if this option was chosen, but time will show that digital imaging won’t help increase employee and staff input of data. The third option, which Mr. D’ Alonzo and I ultimately recommend is implementing a Web-Enabled EDC system.

Web enabled EDC or electronic data capture improves are timely prescription drug testing process significantly. Investigator sites automatically put information on patients into the system. Sponsor or CRA’s instantly get data, can quickly review and then can reject or pass along to the next step.  In some situations, additional computer training will be required at the investigator site and as with anything else there will be some slight resistance with change. Regardless, sir, Wed Enabled EDC in some cases reduced the overall process from 8 weeks to 1. This is an extraordinary increase in efficiency that should not be ignored. I adamantly suggest the immediate implementation of this technology and with your permission will head and properly execute it through any growing pains.

Reflection/Review of Presentation (2/13/13)
                
             Ladies and Gentleman of the board after reviewing yesterday’s presentation, allow well done, several adjustments could have been to make our decision easier. To start a more accurate and clear depiction of cost would have been appropriate. I believe several cost factors were not included and the presentation made it difficult to track the root of some of our major expenses. Second, I believe a biased view was formed on behalf of the presenters. They continuously labored on the advantages of EDC, rather than fully explore every detailed alternative. Regardless of several technicalities, the presentation was informative and granted us the ability understand the situation at hand. In conclusion, I believe it is in our best interest to immediately implement this relatively new technology, EDC. The increased efficiency will allow us to gain a competitive advantage and flourish in the future.

No comments:

Post a Comment